159 related articles for article (PubMed ID: 26932526)
1. Biological evaluation of the toxicity and the cell cycle interruption by some benzimidazole derivatives.
Błaszczak-Świątkiewicz K; Sikora J; Szymański J; Danilewicz M; Mikiciuk-Olasik E
Tumour Biol; 2016 Aug; 37(8):11135-45. PubMed ID: 26932526
[TBL] [Abstract][Full Text] [Related]
2. Some characteristics of activity of potential chemotherapeutics--benzimidazole derivatives.
Błaszczak-Świątkiewicz K; Mikiciuk-Olasik E
Adv Med Sci; 2015 Mar; 60(1):125-32. PubMed ID: 25725479
[TBL] [Abstract][Full Text] [Related]
3. Biological evaluation of the activity of some benzimidazole-4,7-dione derivatives.
Błaszczak-Świątkiewicz K; Mikiciuk-Olasik E
Molecules; 2014 Sep; 19(10):15361-73. PubMed ID: 25264827
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and preliminary evaluation of selected 2-aryl-5(6)-nitro- 1H-benzimidazole derivatives as potential anticancer agents.
Romero-Castro A; León-Rivera I; Avila-Rojas LC; Navarrete-Vázquez G; Nieto-Rodríguez A
Arch Pharm Res; 2011 Feb; 34(2):181-9. PubMed ID: 21380799
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of new benzimidazole-thiazolidinedione hybrids as potential cytotoxic and apoptosis inducing agents.
Sharma P; Srinivasa Reddy T; Thummuri D; Senwar KR; Praveen Kumar N; Naidu VGM; Bhargava SK; Shankaraiah N
Eur J Med Chem; 2016 Nov; 124():608-621. PubMed ID: 27614408
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative activity of new benzimidazole derivatives.
Błaszczak-Świątkiewicz K; Olszewska P; Mikiciuk-Olasik E
Acta Biochim Pol; 2013; 60(3):427-33. PubMed ID: 23888297
[TBL] [Abstract][Full Text] [Related]
7. Biological approach of anticancer activity of new benzimidazole derivatives.
Błaszczak-Świątkiewicz K; Olszewska P; Mikiciuk-Olasik E
Pharmacol Rep; 2014 Feb; 66(1):100-6. PubMed ID: 24905314
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro cytotoxic evaluation of some thiazolylbenzimidazole derivatives.
Luo Y; Xiao F; Qian S; Lu W; Yang B
Eur J Med Chem; 2011 Jan; 46(1):417-22. PubMed ID: 21115212
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of 1,3-diphenyl-1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents.
Reddy TS; Kulhari H; Reddy VG; Bansal V; Kamal A; Shukla R
Eur J Med Chem; 2015 Aug; 101():790-805. PubMed ID: 26231080
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, anticancer activity and UPLC analysis of the stability of some new benzimidazole-4,7-dione derivatives.
Błaszczak-Swiatkiewicz K; Almeida DC; De Jesus Perry M; Mikiciuk-Olasik E
Molecules; 2013 Dec; 19(1):400-13. PubMed ID: 24384922
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents.
Shao KP; Zhang XY; Chen PJ; Xue DQ; He P; Ma LY; Zheng JX; Zhang QR; Liu HM
Bioorg Med Chem Lett; 2014 Aug; 24(16):3877-81. PubMed ID: 25001482
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro antiproliferative evaluation of some B-norcholesteryl Benzimidazole and Benzothiazole derivatives.
Cui J; Qi B; Gan C; Liu Z; Huang H; Lin Q; Zhao D; Huang Y
Mar Drugs; 2015 Apr; 13(4):2488-504. PubMed ID: 25913705
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic, Antiproliferative and Apoptotic Effects of New Benzimidazole Derivatives on A549 Lung Carcinoma and C6 Glioma Cell Lines.
Yurttas L; Demirayak S; Ciftci GA
Anticancer Agents Med Chem; 2015; 15(9):1174-84. PubMed ID: 26138412
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel benzimidazole-2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents.
Wu LT; Jiang Z; Shen JJ; Yi H; Zhan YC; Sha MQ; Wang Z; Xue ST; Li ZR
Eur J Med Chem; 2016 May; 114():328-36. PubMed ID: 27017265
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
Yoon YK; Ali MA; Wei AC; Choon TS; Osman H; Parang K; Shirazi AN
Bioorg Med Chem; 2014 Jan; 22(2):703-10. PubMed ID: 24387981
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle disruption and apoptotic activity of 3-aminothiazolo[3,2-a]benzimidazole-2-carbonitrile and its homologues.
Sarhan AA; Al-Dhfyan A; Al-Mozaini MA; Adra CN; Aboul-Fadl T
Eur J Med Chem; 2010 Jun; 45(6):2689-94. PubMed ID: 20226574
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, antitumor activity and SAR study of novel [1,2,4]triazino[4,5-a]benzimidazole derivatives.
El-Nassan HB
Eur J Med Chem; 2012 Jul; 53():22-7. PubMed ID: 22542105
[TBL] [Abstract][Full Text] [Related]
18. Conventional and microwave-assisted synthesis of new 1H-benzimidazole-thiazolidinedione derivatives: A potential anticancer scaffold.
Sharma P; Reddy TS; Kumar NP; Senwar KR; Bhargava SK; Shankaraiah N
Eur J Med Chem; 2017 Sep; 138():234-245. PubMed ID: 28668476
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anticancer activity of novel benzimidazole and benzothiazole derivatives against HepG2 liver cancer cells.
Youssef AM; Malki A; Badr MH; Elbayaa RY; Sultan AS
Med Chem; 2012 Mar; 8(2):151-62. PubMed ID: 22385181
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxic evaluation of novel 2-(4-(2,2,2-trifluoroethoxy)-3-methylpyridin-2-ylthio)-1H-benzo[d]imidazole derivatives.
Ranganatha SR; Kavitha CV; Vinaya K; Prasanna DS; Chandrappa S; Raghavan SC; Rangappa KS
Arch Pharm Res; 2009 Oct; 32(10):1335-43. PubMed ID: 19898794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
